Bayer AG (BAYRY)
7.26
-0.11
(-1.49%)
USD |
OTCM |
Apr 24, 16:00
Bayer Price to Book Value: 0.7838 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 0.7838 |
| April 23, 2024 | 0.7957 |
| April 22, 2024 | 0.7941 |
| April 19, 2024 | 0.7644 |
| April 18, 2024 | 0.7601 |
| April 17, 2024 | 0.7617 |
| April 16, 2024 | 0.7525 |
| April 15, 2024 | 0.7579 |
| April 12, 2024 | 0.7752 |
| April 11, 2024 | 0.7914 |
| April 10, 2024 | 0.8054 |
| April 09, 2024 | 0.8076 |
| April 08, 2024 | 0.8054 |
| April 05, 2024 | 0.8151 |
| April 04, 2024 | 0.8259 |
| April 03, 2024 | 0.84 |
| April 02, 2024 | 0.8108 |
| April 01, 2024 | 0.8259 |
| March 28, 2024 | 0.827 |
| March 27, 2024 | 0.8281 |
| March 26, 2024 | 0.7957 |
| March 25, 2024 | 0.7871 |
| March 22, 2024 | 0.7774 |
| March 21, 2024 | 0.7741 |
| March 20, 2024 | 0.7698 |
| Date | Value |
|---|---|
| March 19, 2024 | 0.7548 |
| March 18, 2024 | 0.7666 |
| March 15, 2024 | 0.7709 |
| March 14, 2024 | 0.7644 |
| March 13, 2024 | 0.7828 |
| March 12, 2024 | 0.7817 |
| March 11, 2024 | 0.7892 |
| March 08, 2024 | 0.772 |
| March 07, 2024 | 0.7774 |
| March 06, 2024 | 0.7838 |
| March 05, 2024 | 0.7633 |
| March 04, 2024 | 0.827 |
| March 01, 2024 | 0.8281 |
| February 29, 2024 | 0.8195 |
| February 28, 2024 | 0.8357 |
| February 27, 2024 | 0.8508 |
| February 26, 2024 | 0.8335 |
| February 23, 2024 | 0.8378 |
| February 22, 2024 | 0.8421 |
| February 21, 2024 | 0.8443 |
| February 20, 2024 | 0.8389 |
| February 16, 2024 | 0.8357 |
| February 15, 2024 | 0.8227 |
| February 14, 2024 | 0.8216 |
| February 13, 2024 | 0.8108 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7525
Minimum
Apr 16 2024
1.851
Maximum
Jul 06 2020
1.383
Average
1.419
Median
Aug 01 2023
Price to Book Value Benchmarks
| Affimed NV | 1.163 |
| InflaRx NV | 0.7062 |
| MorphoSys AG | 50.07 |
| BioNTech SE | 0.9357 |
| Immatics NV | 4.201 |
Price to Book Value Related Metrics
| PS Ratio | 0.5536 |
| Price to Free Cash Flow | 11.14 |
| Price | 7.26 |
| Earnings Yield | -11.39% |
| Market Cap | 28.53B |
| Operating PE Ratio | 3.321 |